Online hemoglobin monitoring could improve management of anemia in hemodialysis patients
Rachael Williams
This article has no abstract so we have provided the first paragraph of the full text.
Less frequent blood tests would undoubtedly enhance the quality of life of hemodialysis patients. Optical devices for measurement of hemoglobin concentration have been incorporated into dialysis monitors for some time, but have only been used to assess relative blood volume. Now researchers have shown that the Hemoscan® (Cytometrics Inc., Philadelphia, PA)—a device that surveys the light absorbed by blood flowing through a dialysis machine—can continuously measure absolute hemoglobin concentrations with accuracy and reliability equivalent to laboratory-based determinations.
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
